CTNNB1 and breast cancer: For instance, recent evidence shows the Wnt/beta-catenin pathway as a promoting factor in breast tumor drug resistance and the inhibition of the pathway by alkaloids indeed enhanced the efficacy of common chemotherapeutics in breast cancer [72].